AstraZeneca Hong Kong and Macau, established in 1990, is a branch of the global, science-led biopharmaceutical company AstraZeneca. The company focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas: Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca Hong Kong and Macau is committed to delivering life-changing medicines and has been continually expanding its business to meet the growing demand in the region. The company also collaborates with local associations and non-governmental organizations to provide patient affordability programs and empowerment initiatives in various disease areas.